Tasly Pharmaceutical Group Co Ltd (600535) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.044x

Based on the latest financial reports, Tasly Pharmaceutical Group Co Ltd (600535) has a cash flow conversion efficiency ratio of 0.044x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥552.13 Million ≈ $80.79 Million USD) by net assets (CN¥12.55 Billion ≈ $1.84 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how many days can Tasly Pharmaceutical Group Co Ltd fund operations to measure how many days the company can operate on defensive assets alone.

Tasly Pharmaceutical Group Co Ltd - Cash Flow Conversion Efficiency Trend (2001–2025)

This chart illustrates how Tasly Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Tasly Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Tasly Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Sigma Advanced Systems Limited NSE:MEGASOFT	-0.777x
Green Brick Partners Inc NYSE:GRBK	0.028x
TOTVS S.A SA:TOTS3	0.058x
TechCreate Group Ltd. NYSE MKT:TCGL	0.526x
Wingtech Technology Co Ltd SHG:600745	0.048x
Sany Heavy Equipment International Holdings Company Limited F:YXS	0.017x
Chemours Co NYSE:CC	0.487x
Aneka Tambang (Persero) TBK (PT) AU:ATM	-0.079x

Annual Cash Flow Conversion Efficiency for Tasly Pharmaceutical Group Co Ltd (2001–2025)

The table below shows the annual cash flow conversion efficiency of Tasly Pharmaceutical Group Co Ltd from 2001 to 2025. For the full company profile with market capitalisation and key ratios, see 600535 market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥12.55 Billion ≈ $1.84 Billion	CN¥1.42 Billion ≈ $208.49 Million	0.114x	-31.74%
2024-12-31	CN¥12.11 Billion ≈ $1.77 Billion	CN¥2.01 Billion ≈ $294.79 Million	0.166x	-18.05%
2023-12-31	CN¥12.69 Billion ≈ $1.86 Billion	CN¥2.58 Billion ≈ $376.90 Million	0.203x	+12.19%
2022-12-31	CN¥12.63 Billion ≈ $1.85 Billion	CN¥2.29 Billion ≈ $334.39 Million	0.181x	-14.01%
2021-12-31	CN¥13.31 Billion ≈ $1.95 Billion	CN¥2.80 Billion ≈ $409.90 Million	0.210x	+45.47%
2020-12-31	CN¥12.38 Billion ≈ $1.81 Billion	CN¥1.79 Billion ≈ $262.10 Million	0.145x	+2.12%
2019-12-31	CN¥11.86 Billion ≈ $1.74 Billion	CN¥1.68 Billion ≈ $245.86 Million	0.142x	+6.27%
2018-12-31	CN¥11.21 Billion ≈ $1.64 Billion	CN¥1.49 Billion ≈ $218.59 Million	0.133x	+245.41%
2017-12-31	CN¥8.97 Billion ≈ $1.31 Billion	CN¥-822.56 Million ≈ $-120.37 Million	-0.092x	-165.20%
2016-12-31	CN¥8.21 Billion ≈ $1.20 Billion	CN¥1.15 Billion ≈ $168.83 Million	0.141x	+218.67%
2015-12-31	CN¥7.71 Billion ≈ $1.13 Billion	CN¥340.00 Million ≈ $49.75 Million	0.044x	-63.75%
2014-12-31	CN¥5.07 Billion ≈ $741.67 Million	CN¥616.76 Million ≈ $90.25 Million	0.122x	+45.65%
2013-12-31	CN¥4.14 Billion ≈ $606.32 Million	CN¥346.17 Million ≈ $50.66 Million	0.084x	-14.97%
2012-12-31	CN¥4.21 Billion ≈ $615.55 Million	CN¥413.31 Million ≈ $60.48 Million	0.098x	+174.55%
2011-12-31	CN¥3.78 Billion ≈ $552.55 Million	CN¥135.14 Million ≈ $19.77 Million	0.036x	-68.97%
2010-12-31	CN¥3.42 Billion ≈ $501.18 Million	CN¥395.05 Million ≈ $57.81 Million	0.115x	-37.45%
2009-12-31	CN¥2.17 Billion ≈ $317.70 Million	CN¥400.39 Million ≈ $58.59 Million	0.184x	+48.33%
2008-12-31	CN¥2.09 Billion ≈ $306.26 Million	CN¥260.21 Million ≈ $38.08 Million	0.124x	+10.81%
2007-12-31	CN¥1.97 Billion ≈ $288.96 Million	CN¥221.55 Million ≈ $32.42 Million	0.112x	+37.29%
2006-12-31	CN¥1.72 Billion ≈ $251.70 Million	CN¥140.56 Million ≈ $20.57 Million	0.082x	-40.49%
2005-12-31	CN¥1.56 Billion ≈ $229.00 Million	CN¥214.90 Million ≈ $31.45 Million	0.137x	-7.13%
2004-12-31	CN¥1.37 Billion ≈ $201.15 Million	CN¥203.27 Million ≈ $29.74 Million	0.148x	+201.11%
2003-12-31	CN¥1.20 Billion ≈ $175.82 Million	CN¥59.00 Million ≈ $8.63 Million	0.049x	-76.26%
2002-12-31	CN¥997.00 Million ≈ $145.89 Million	CN¥206.22 Million ≈ $30.18 Million	0.207x	-38.96%
2001-12-31	CN¥247.20 Million ≈ $36.17 Million	CN¥83.77 Million ≈ $12.26 Million	0.339x	--

About Tasly Pharmaceutical Group Co Ltd

SHG:600535 China Drug Manufacturers - Specialty & Generic

Market Cap

$3.08 Billion

CN¥21.05 Billion CNY

Market Cap Rank

#4931 Global

#909 in China

Share Price

CN¥14.09

Change (1 day)

-0.07%

52-Week Range

CN¥13.52 - CN¥17.41

All Time High

CN¥29.37